These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
512 related items for PubMed ID: 16689976
21. Vitamin D-independent therapeutic effects of extracellular calcium in a mouse model of adult-onset secondary hyperparathyroidism. Weber K, Bergow C, Hirmer S, Schüler C, Erben RG. J Bone Miner Res; 2009 Jan; 24(1):22-32. PubMed ID: 18767932 [Abstract] [Full Text] [Related]
22. Reversal of secondary hyperparathyroidism by phosphate restriction restores parathyroid calcium-sensing receptor expression and function. Ritter CS, Martin DR, Lu Y, Slatopolsky E, Brown AJ. J Bone Miner Res; 2002 Dec; 17(12):2206-13. PubMed ID: 12469914 [Abstract] [Full Text] [Related]
23. Local NF-κB Activation Promotes Parathyroid Hormone Synthesis and Secretion in Uremic Patients. Mao J, Wang M, Ni L, Gong W, Jiang X, Zhang Q, Zhang M, Wen D, Chen J. Endocrinology; 2021 Jul 01; 162(7):. PubMed ID: 33912936 [Abstract] [Full Text] [Related]
24. Cinacalcet HCl prevents development of parathyroid gland hyperplasia and reverses established parathyroid gland hyperplasia in a rodent model of CKD. Miller G, Davis J, Shatzen E, Colloton M, Martin D, Henley CM. Nephrol Dial Transplant; 2012 Jun 01; 27(6):2198-205. PubMed ID: 22036941 [Abstract] [Full Text] [Related]
25. [The mechanisms of parathyroid hyperplasia and its regression]. Tokumoto M, Taniguchi M. Clin Calcium; 2007 May 01; 17(5):665-76. PubMed ID: 17470994 [Abstract] [Full Text] [Related]
26. Decreased calcium-sensing receptor expression in hyperplastic parathyroid glands of uremic rats: role of dietary phosphate. Brown AJ, Ritter CS, Finch JL, Slatopolsky EA. Kidney Int; 1999 Apr 01; 55(4):1284-92. PubMed ID: 10200992 [Abstract] [Full Text] [Related]
27. A direct effect in vitro of phosphate on PTH release from bovine parathyroid tissue slices but not from dispersed parathyroid cells. Nielsen PK, Feldt-Rasmussen U, Olgaard K. Nephrol Dial Transplant; 1996 Sep 01; 11(9):1762-8. PubMed ID: 8918619 [Abstract] [Full Text] [Related]
28. A high body mass index and female gender are associated with an increased risk of nodular hyperplasia of parathyroid glands in chronic uraemia. Basile C, Lomonte C, Vernaglione L, Casucci F, Chimienti D, Bruno A, Cocola S, Verrelli EA, Cazzato F. Nephrol Dial Transplant; 2006 Apr 01; 21(4):968-74. PubMed ID: 16326747 [Abstract] [Full Text] [Related]
29. Highly concentrated calcitriol and its analogues induce apoptosis of parathyroid cells and regression of the hyperplastic gland--study in rats. Shiizaki K, Hatamura I, Negi S, Sakaguchi T, Saji F, Imazeki I, Kusano E, Shigematsu T, Akizawa T. Nephrol Dial Transplant; 2008 May 01; 23(5):1529-36. PubMed ID: 18156462 [Abstract] [Full Text] [Related]
30. New therapies for uremic secondary hyperparathyroidism. Torres PU, Prié D, Beck L, Friedlander G. J Ren Nutr; 2006 Apr 01; 16(2):87-99. PubMed ID: 16567265 [Abstract] [Full Text] [Related]
31. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Gene therapy for secondary hyperparathyroidism]. Kanai G, Fukagawa M. Clin Calcium; 2010 Jul 01; 20(7):1052-9. PubMed ID: 20585184 [Abstract] [Full Text] [Related]
32. Histopathology and pathophysiology of secondary hyperparathyroidism due to chronic renal failure. Tominaga Y, Sato K, Tanaka Y, Numano M, Uchida K, Takagi H. Clin Nephrol; 1995 Nov 01; 44 Suppl 1():S42-7. PubMed ID: 8608662 [Abstract] [Full Text] [Related]
33. [Cell proliferation of parathyroid gland in patients with progressive secondary hyperparathyroidism: Vitamin D receptor, calcium sensing receptor, and cell cycle regulation factor]. Tokumoto M, Taniguchi M, Matsuo D, Tsuruya K, Hirakata H, Iida M. Clin Calcium; 2005 Sep 01; 15 Suppl 1():206-16. PubMed ID: 16279026 [No Abstract] [Full Text] [Related]
34. Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. Fukuda N, Tanaka H, Tominaga Y, Fukagawa M, Kurokawa K, Seino Y. J Clin Invest; 1993 Sep 01; 92(3):1436-43. PubMed ID: 8397225 [Abstract] [Full Text] [Related]
35. [Effect of calcium on N-terminal truncation of PTH in human parathyroid cells]. Kawata T, Imanishi Y, Kobayashi K, Tahara H, Ishimura E, Inaba M, Nishizawa Y, Takemoto Y, Onoda N, Okuno S, Ishikawa T. Clin Calcium; 2005 Sep 01; 15 Suppl 1():98-100; discussion 100-1. PubMed ID: 16279017 [Abstract] [Full Text] [Related]
36. [Regulation of the calcium-sensing receptor. Influence of secondary hyperparathyroidism]. Fernández Martín JL, González Suárez I, Cannata Andía JB. Nefrologia; 2003 Sep 01; 23 Suppl 2():7-11. PubMed ID: 12778846 [Abstract] [Full Text] [Related]
37. Bone disease in uremic patients: advances in PTH suppression. Brancaccio D, Cozzolino M, Gorio A, Di Giulio AM, Gallieni M. J Nephrol; 2002 Sep 01; 15 Suppl 6():S86-93. PubMed ID: 12515379 [Abstract] [Full Text] [Related]
38. Overproduction and secretion of a novel amino-terminal form of parathyroid hormone from a severe type of parathyroid hyperplasia in uremia. Arakawa T, D'Amour P, Rousseau L, Brossard JH, Sakai M, Kasumoto H, Igaki N, Goto T, Cantor T, Fukagawa M. Clin J Am Soc Nephrol; 2006 May 01; 1(3):525-31. PubMed ID: 17699255 [Abstract] [Full Text] [Related]
40. Parathyroid hormone immunohistochemistry in dogs with primary and secondary hyperparathyroidism: the question of adenoma and primary hyperplasia. van Vonderen IK, Kooistra HS, Peeters ME, Rijnberk A, van den Ingh TS. J Comp Pathol; 2003 Jul 01; 129(1):61-9. PubMed ID: 12859909 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]